80 related articles for article (PubMed ID: 6845300)
1. [Drug therapy of malignant melanoma based on a cell culture test].
Tveit KM; Gundersen S; Vaage S
Tidsskr Nor Laegeforen; 1983 Jan; 103(2):117-9. PubMed ID: 6845300
[No Abstract] [Full Text] [Related]
2. [Anti-oncogram-assisted treatment planning in malignant melanoma].
Metelmann HR; Von Hoff D
Fortschr Kiefer Gesichtschir; 1988; 33():168-70. PubMed ID: 3165923
[No Abstract] [Full Text] [Related]
3. Update on in vitro testing on new drugs in ovarian cancer and melanoma.
Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
Cancer Treat Rep; 1981; 65(5-6):532-3. PubMed ID: 7195308
[No Abstract] [Full Text] [Related]
4. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.
Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
Cancer Treat Rep; 1981; 65(1-2):1-12. PubMed ID: 7226159
[TBL] [Abstract][Full Text] [Related]
5. [Individualized drug therapy of cancer based on an in vitro test].
Tveit KM
Tidsskr Nor Laegeforen; 1983 Jan; 103(2):113-6. PubMed ID: 6845299
[No Abstract] [Full Text] [Related]
6. Adjuvant therapy for malignant melanoma.
Stoutenburg JP; Schrope B; Kaufman HL
Expert Rev Anticancer Ther; 2004 Oct; 4(5):823-35. PubMed ID: 15485316
[TBL] [Abstract][Full Text] [Related]
7. [Malignant melanoma - adjuvant systemic therapy].
Schreml W
Aktuelle Probl Chir Orthop; 1982; 22():64-5. PubMed ID: 6121516
[No Abstract] [Full Text] [Related]
8. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
Alberts DS; Mackel C; Pocelinko R; Salmon SE
Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
[TBL] [Abstract][Full Text] [Related]
9. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
Wong SF; Jakowatz JG; Taheri R
Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
[TBL] [Abstract][Full Text] [Related]
10. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
11. [In vitro drug sensitivity profiling in melanoma].
Ugurel S
J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
[No Abstract] [Full Text] [Related]
12. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture.
Tanigawa N; Kern DH; Hikasa Y; Morton DL
Cancer Res; 1982 Jun; 42(6):2159-64. PubMed ID: 7074595
[No Abstract] [Full Text] [Related]
13. Melanoma and chemotherapy.
Aust JB
Prog Clin Cancer; 1975; 6():199-204. PubMed ID: 53859
[No Abstract] [Full Text] [Related]
14. Malignant melanoma.
Schwartsmann G; Parkinson DR
Cancer Chemother Biol Response Modif; 1993; 14():577-93. PubMed ID: 8312120
[No Abstract] [Full Text] [Related]
15. Chemotherapy and immunotherapy for malignant melanoma.
Richman SP; Gutterman JU; Hersh EM
Compr Ther; 1980 Oct; 6(10):57-61. PubMed ID: 7449366
[No Abstract] [Full Text] [Related]
16. Phase II study of AMSA in patients with metastatic malignant melanoma.
Houghton AM; Camacho F; Wittes R; Young CW
Cancer Treat Rep; 1981; 65(1-2):170-1. PubMed ID: 6894401
[No Abstract] [Full Text] [Related]
17. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
Retsas S; Thomas C; Hobbs JR
Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
[No Abstract] [Full Text] [Related]
18. Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma.
Fuks JZ; Van Echo DA; Aisner J; Schipper H; Levitt M; Wiernik PH
Cancer Treat Rep; 1982 May; 66(5):1237-8. PubMed ID: 7083226
[No Abstract] [Full Text] [Related]
19. Dacarbazine for malignant melanoma.
Med Lett Drugs Ther; 1974 Mar; 16(6):27-8. PubMed ID: 4817357
[No Abstract] [Full Text] [Related]
20. Individualized therapy of disseminated cancer using malignant melanoma as a model.
Hauschild A; Egberts F; Russo P; Kähler KC
Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
